These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19329427)

  • 1. Domain interplay mediated by an essential disulfide linkage is critical for the activity and secretion of the metastasis-promoting enzyme autotaxin.
    Jansen S; Andries M; Derua R; Waelkens E; Bollen M
    J Biol Chem; 2009 May; 284(21):14296-302. PubMed ID: 19329427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential oligomannosidic glycan chain in the catalytic domain of autotaxin, a secreted lysophospholipase-D.
    Jansen S; Callewaert N; Dewerte I; Andries M; Ceulemans H; Bollen M
    J Biol Chem; 2007 Apr; 282(15):11084-91. PubMed ID: 17307740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
    Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
    Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.
    Jansen S; Stefan C; Creemers JW; Waelkens E; Van Eynde A; Stalmans W; Bollen M
    J Cell Sci; 2005 Jul; 118(Pt 14):3081-9. PubMed ID: 15985467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of NPP1, an ectonucleotide pyrophosphatase/phosphodiesterase involved in tissue calcification.
    Jansen S; Perrakis A; Ulens C; Winkler C; Andries M; Joosten RP; Van Acker M; Luyten FP; Moolenaar WH; Bollen M
    Structure; 2012 Nov; 20(11):1948-59. PubMed ID: 23041369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
    Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
    Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of substrate discrimination and integrin binding by autotaxin.
    Hausmann J; Kamtekar S; Christodoulou E; Day JE; Wu T; Fulkerson Z; Albers HM; van Meeteren LA; Houben AJ; van Zeijl L; Jansen S; Andries M; Hall T; Pegg LE; Benson TE; Kasiem M; Harlos K; Kooi CW; Smyth SS; Ovaa H; Bollen M; Morris AJ; Moolenaar WH; Perrakis A
    Nat Struct Mol Biol; 2011 Feb; 18(2):198-204. PubMed ID: 21240271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1.
    Gijsbers R; Ceulemans H; Bollen M
    Biochem J; 2003 Apr; 371(Pt 2):321-30. PubMed ID: 12533192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
    van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
    J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
    Gijsbers R; Aoki J; Arai H; Bollen M
    FEBS Lett; 2003 Mar; 538(1-3):60-4. PubMed ID: 12633853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases.
    Gijsbers R; Ceulemans H; Stalmans W; Bollen M
    J Biol Chem; 2001 Jan; 276(2):1361-8. PubMed ID: 11027689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation of Autotaxin: roles of the nuclease-like domain and the glycan modification.
    Koyama M; Nishimasu H; Ishitani R; Nureki O
    J Phys Chem B; 2012 Oct; 116(39):11798-808. PubMed ID: 22967301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of ectonucleotide phosphodiesterase/pyrophosphatase-3 and orientation of the SMB domains in the full-length ectodomain.
    Döhler C; Zebisch M; Krinke D; Robitzki A; Sträter N
    Acta Crystallogr F Struct Biol Commun; 2018 Nov; 74(Pt 11):696-703. PubMed ID: 30387774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide pyrophosphatases/phosphodiesterases on the move.
    Bollen M; Gijsbers R; Ceulemans H; Stalmans W; Stefan C
    Crit Rev Biochem Mol Biol; 2000; 35(6):393-432. PubMed ID: 11202013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
    van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
    Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.
    Sakagami H; Aoki J; Natori Y; Nishikawa K; Kakehi Y; Natori Y; Arai H
    J Biol Chem; 2005 Jun; 280(24):23084-93. PubMed ID: 15788404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells.
    Jansen S; Andries M; Vekemans K; Vanbilloen H; Verbruggen A; Bollen M
    Cancer Lett; 2009 Nov; 284(2):216-21. PubMed ID: 19482419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein.
    Hausmann J; Christodoulou E; Kasiem M; De Marco V; van Meeteren LA; Moolenaar WH; Axford D; Owen RL; Evans G; Perrakis A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Sep; 66(Pt 9):1130-5. PubMed ID: 20823545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a pipemidic acid autotaxin inhibitor.
    Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
    J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.